Serum lncRNA ANRIL, miR-186, miR-181a, and MTMR-3 could be used as potential biomarkers for the diagnosis of preeclampsia that may be used as therapeutic targets. This evidence concerns the gene CDKN2B-AS1 and preeclampsia.